SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that the Trump administration may be considering easing federal marijuana restrictions, potentially reclassifying it as a Schedule III drug. The community is actively discussing target prices and potential short squeezes, while also speculating on how Tilray and other cannabis stocks will react to the potential policy change.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining traction as discussions around cannabis reform intensify, with community members highlighting its potential role in the cultural shift. The project, built on Solana, is described as a culture coin with a focus on long-term growth and a strong community vibe. Some users are drawing parallels to Bitcoin, emphasizing Weedcoin's potential within the cannabis culture.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is experiencing volatility following earnings, initially jumping on strong AI chip demand and guidance, but then declining due to profit-taking and concerns about non-AI revenue. The community is actively debating whether the pullback is a buying opportunity or a sign of an overvalued stock, with some pointing to potential gross margin compression and dependence on OpenAI revenue as causes for concern. Despite the mixed sentiment, underlying AI demand remains a key talking point, with analysts weighing in on future target prices.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors anticipate upcoming catalysts, including 48-week data and an FDA meeting, while closely monitoring the competitive landscape of MASH and obesity treatments. Community members are debating the potential impact of these events, with some expressing concerns about trial endpoints and others highlighting the company's leadership changes as a signal for a potential partnership or buyout. Discussions also revolve around efforts to manage expectations, counter misinformation, and interpret technical indicators amidst mixed opinions on the stock's near-term prospects.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amid discussions about potential partnerships with projects like XRP and general excitement surrounding its ecosystem. Community members are also actively discussing Solana-based meme coins like WEEDCOIN and PMV, contributing to the increased attention. Additionally, some analysts point to upcoming catalysts and favorable technical indicators, further fueling positive sentiment.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending amidst high volatility and a wide range of community perspectives, with some traders citing the stock's low float and potential for a squeeze. Discussions revolve around a recent surge in price followed by a sharp decline, leaving investors debating whether to hold for a potential rebound or exit. The conversation also includes speculation about upcoming announcements, and potential catalysts.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending following a Q3 earnings beat, a raised full-year guidance, and the announcement of a CEO succession plan and a buyback program. The community is discussing the potential for analyst upgrades and the impact of international business, particularly in China, on the company's future growth. Some traders are noting overnight gains and anticipating a continued run, while others express concerns about overnight crashes and are eyeing the $225-$240 range.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors digest the potential impacts of both competitor Broadcom's earnings and news regarding AI chip exports to China. The community is actively discussing AMD's valuation, potential catalysts, and technical indicators for possible breakouts, with some focusing on long-term growth prospects. Some traders are also pointing to the potential of an island reversal.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chun Sing Chan on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to community excitement around its low float and potential for a squeeze, drawing comparisons to other recent runners like $SMX.  Anticipation is building for news related to acquisitions and the company's crypto treasury, which some believe could act as a catalyst.  The stock's Hong Kong connection and potential undervaluation are also key talking points.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

$KENDU is trending as community members rally around the project's ongoing development and expansion of its IRL presence through various ventures. The community is actively discussing its strong conviction and dedication to building a global brand, highlighting the unique initiatives and real-world products associated with the token.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hagens Berman Investigating Rezolute, Inc. (RZLT) as Shares Tank 90% Amid Lead Asset Trial Failure

On December 11, 2025, investors in Rezolute, Inc. (NASDAQ: RZLT) saw the price of their shares crater as much as 90% during intraday trading after the company revealed the failure of its Phase 3...

Rezolute, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights RZLT

The DJS Law Group announces that it is investigating claims on behalf of investors of Rezolute, Inc. (Rezolute or the Company) (NASDAQ: RZLT) for violations of the securities laws. INVESTIGATION...

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rezolute, Inc. (Rezolute or the Company) (NASDAQ: RZLT). This press release features...

Why Is XOMA Royalty Stock Sinking Thursday?

XOMA stock plunged after its partner Rezolute Inc. reported disappointing trial results for their product Ersodetug.read more...

Rezolute (NASDAQ:RZLT) Downgraded by Wedbush to "Neutral"

Wedbush cut Rezolute from an "outperform" rating to a "neutral" rating and set a $1.00 price target for the company. in a research note on Thursday...

<ul class="summary-bullets"><li>RZLT stock dropped to its lowest level since February 2024.</li><li>The study also missed its key secondary endpoint, the company said.</li><li>Rezolute said that its Phase 3 upLIFT study in tumour-related hyperinsulinism is underway, with topline results expected in the second half of 2026.</li></ul>Shares of Rezolute, Inc. (RZLT) collapsed nearly 90% on Thursday, after the company reported that its Phase 3 sunRIZE trial of ersodetug to treat low blood pressure failed to meet its primary endpoint.Following the decline, <a href="https://stocktwits.com/symbol/RZLT">RZLT</a> stock fell below its 200-day moving average (200-DMA) for the first time since April 2024 and dropped to its lowest level since February 2024, with trading halted just minutes after the opening bell.<figure class="image"><img style="aspect-ratio:1311/867;" src="https://news.stocktwits-cdn.com/RZLT_png_3ccc7478ed.webp" alt="RZLT.png" width="1311" height="867"><figcaption>RZLT 200-DMA | Source: TradingView</figcaption></figure><h2 class="st-heading-2">What Did The Study Show?</h2>Rezolute reported topline Phase 3 sunRIZE results showing that ersodetug failed to meet its primary endpoint in patients with congenital hyperinsulinism, as the treatment did not reduce weekly hypoglycemia events based on self-monitored blood glucose readings.At the highest dose of 10 mg/kg, ersodetug showed a roughly 45% reduction in hypoglycemia events, but this was not statistically significant compared with the placebo group, which saw a 40% improvement.The study also missed its key secondary endpoint, which assessed changes in daily time spent in hypoglycemia through continuous glucose monitoring. Patients on the 10 mg/kg dose experienced about a 25% reduction in time spent in low blood sugar, but this improvement did not differ significantly from placebo, which showed a 5% increase.Despite the lack of efficacy signals, Rezolute said the achieved drug levels were consistent with expectations across all ages, and the overall safety profile was favorable. Two participants experienced severe hypersensitivity reactions that required stopping treatment, but the company noted that the overall incidence of serious allergic reactions was low. The most common side effect was hypertrichosis, a condition that causes temporary hair growth.“We are disappointed that the study did not demonstrate significant improvements in glucose-related endpoints relative to placebo as well as for the patients and families living with congenital HI who urgently need new treatment options. At the same time, there are aspects of the results that merit additional investigation, and we are conducting a thorough evaluation to gain a better understanding of the study outcomes, which will inform our path forward,” said Brian Roberts, Chief Medical Officer of Rezolute.&nbsp;“We intend to meet with FDA under our Breakthrough Therapy Designation to consider next steps for the program.”&nbsp;&nbsp;Rezolute said that its Phase 3 upLIFT study in tumour-related hyperinsulinism is underway, and topline results are expected in the second half of 2026.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday decline, retail sentiment on Stocktwits remained ‘extremely bullish’ over the past 24 hours, accompanied by ‘extremely high’ message volumes.<figure class="image"><img style="aspect-ratio:915/94;" src="https://news.stocktwits-cdn.com/RZLT_png_536276b697.webp" alt="RZLT.png" width="915" height="94"><figcaption>RZLT's Sentiment Meter and Message Volumes at 10:10 a.m. ET on Dec. 11, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user believes the stock is oversold.<stembedurl>https://stocktwits.com/GuyFawkes_EOD/message/638855933</stembedurl>The stock is down over 73% this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/crbp-stock-surged-36-pre-market-what-did-its-obesity-treatment-drug-study-reveal/cLIxOoAREnh">CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ZoomInfo said net revenue retention was stable for the third consecutive quarter. 

RZLT Stock Lost Nearly 90% Of Its Value Today – What Did The Company’s Latest Trial Reveal?

Rezolute said that its Phase 3 sunRIZE trial of ersodetug to treat low blood pressure failed to meet its primary endpoint.

Equity

Rezolute (NASDAQ:RZLT) Trading 7.7% Higher - Here's Why

Rezolute (NASDAQ:RZLT) Trading 7.7% Higher - Still a Buy...

Velan Capital Investment Management LP Has $3.35 Million Stock Position in Rezolute, Inc. $RZLT

Velan Capital Investment Management LP boosted its position in shares of Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 87.5% in the 2nd quarter, according to its most recent filing with the...

Stempoint Capital LP Takes $2.88 Million Position in Rezolute, Inc. $RZLT

Stempoint Capital LP purchased a new position in shares of Rezolute, Inc. (NASDAQ:RZLT - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange...

Geode Capital Management LLC Raises Stock Holdings in Rezolute, Inc. $RZLT

Geode Capital Management LLC increased its stake in Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 201.7% during the 2nd quarter, according to the company in its most recent disclosure with the...

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Rezolute Inc

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

RZLT
Rezolute Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RZLT News

RZLTRezolute Inc